The QualityStocks Daily Friday, March 1st, 2019

Today's Top 3 StockMarketWatch

StocksToBuyNow (HOILF) +207.40%

MarketClub Analysis (BPTH) +49.07%

StockMarketWatch (PBYI) +39.99%

The QualityStocks Daily Stock List

Chemesis International, Inc. (CADMF)

Green Stock Report, Financial Buzz, Insider Financial, Stockhouse, otc.watch, The Street, InvestorsHub, Connecting Investor, Wallmine, Midas Letter, Investing News, MarketWatch, Cannabindex, CannabisFN, Business Insider, Nasdaq.com, Dividend Investor, GuruFocus, YCharts, Morningstar, Seeking Alpha, Market Screener, and Trading View reported on Chemesis International, Inc. (CADMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Chemesis International, Inc. is a vertically integrated worldwide leader in the cannabis industry that lists on the OTC Markets Group’s OTCQB. The Company has facilities in Puerto Rico and California. Chemesis takes advantage of exclusive brands and partnerships and uses the highest quality extraction methods to provide consumers with quality cannabis products. Chemesis International has its corporate headquarters in Vancouver, British Columbia.

The Company operates in the most important and most profitable sectors of the cannabis industry. It is positioned for fast growth in the developing fully-licensed and fully-compliant cannabis industry. Chemesis will grow new markets and revenues within Cultivation, Manufacturing, Distribution and Retail Sales. The Company is presently retailing exclusive products in Puerto Rico and actively engaging retail storefronts in the California marketplace.

At present, Chemesis International has operations underway in Puerto Rico with Natural Ventures, Colombia with La Finca, as well as California with California Sap and Desert Zen. Its state-of-the-art grow facility in Puerto Rico showcases a 2,000-plus grow light capacity and a 30,000-plus lb overall grow capacity.

La Finca brings greater than 1,000 acres of land for cultivation in Colombia. Chemesis has more than 2,000 relationships with farming families, which consist of its land package. Moreover, Desert Zen has emerged as a fully compliant first mover in California. Desert Zen has a fleet of fully compliant vehicles that are servicing California.

Chemesis International is working to open exclusively branded shops in numerous markets. The Company distributes and transports California Sap, Jay and Silent Bob’s Private Stash, and also third party brands to more than 600 dispensaries in California and Puerto Rico.

Recently, Chemesis International announced plans to add an additional 25,000 ft2 of manufacturing, in Cathedral City, California. With the recent commercialization of its fully compliant state-of-the-art extraction facility, Chemesis is moving ahead with the expansion plan and expects completion of the additional manufacturing space by Q2 2019. This facility will be full State compliant for manufacturing, packaging, distribution and transportation. This will allow for products to be distributed directly to State licensed dispensaries.

This week, Chemesis International announced that its subsidiary, Natural Ventures, signed a definitive agreement for an annual purchase order of a minimum total of USD $4,000,000. The Company will cultivate, manufacture, package and distribute for the Puerto Rico based dispensary network from its fully licensed, state compliant facility. The products are white labeled under the dispensaries brand and delivered on a weekly basis. Natural Ventures commenced fulfilling purchase orders in February 2019. It is providing the vendor with edibles, vaporizers, lotions, beverages, and flower.

Chemesis International, Inc. (CADMF), closed Friday's trading session at $1.45, up 7.46%, on 409,052 volume with 487 trades. The average volume for the last 3 months is 92,479 and the stock's 52-week low/high is $0.20/$1.60.

chart

IDM Mining Ltd. (IDMMF)

InvestorsHub, Dividend Investor, Trading View, Republic of Mining, MarketWatch, Stockwatch, Investors Hangout, The Stock Voice, Geology for Investors, Wallmine, Stockhouse, YCharts, and Marketwired reported previously on IDM Mining Ltd. (IDMMF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

IDM Mining Ltd. is a mineral exploration and development company listed on the OTC Markets’ OTCQB. It focuses on low capital expenditure, high-grade precious metal asset development. The Company’s present exploration and development activities center on precious metals in British Columbia (B.C.). The Company’s principal focus is on the high-grade, underground Red Mountain Gold Project. IDM Mining is headquartered in Vancouver, B.C.

The Red Mountain Gold Project is 15 kilometers east of Stewart, B.C. It consists of 17,125 hectares. IDM Mining is advancing through the B.C. and Canadian environmental assessment processes with complete, thorough, and continuing consultation with Nisga'a Nation.

Red Mountain has premier exploration potential for more discoveries along a 12-kilometer trend of many prospects and favorable geology. IDM Mining is advancing a Feasibility Study (FS) for a high-grade, underground gold mine. The Company anticipates primarily bulk underground mining methods and the production of gold doré on site.

Red Mountain hosts a well-drilled, high-grade resource, accessed by a production-sized underground decline. The deposit (at an average potential mining width of 16 meters) is amenable to low-cost bulk mining techniques such as longhole stoping.

IDM Mining completed the 2018 underground drilling program at the advanced-stage Red Mountain Underground Gold Project. It completed the drilling program utilizing three core rigs from a winterized camp and shop facility located next to production-size underground workings.

In January, Ascot Resources Ltd. (OTCQX:AOTVF) and IDM Mining announced that they entered into a definitive arrangement agreement. Ascot Resources will acquire all of the issued and outstanding common shares of IDM. The Transaction will consolidate Ascot’s Premier Gold project and IDM’s Red Mountain project, to form the leading high-grade gold development and exploration company in northwestern B.C.’s Golden Triangle. The combined entity will benefit from manifold operational and development synergies.

In February, IDM Mining announced that final assays were received from 2018 trenching of the Randell Vein area in the Lost Valley region, four kilometers south of the Red Mountain Resource area.  Furthermore, the Company announced surface sampling assays from the Meg, Cambria and Dave's Trench areas on the Red Mountain Property, situated in the Golden Triangle of northwest B.C., 15 kilometers northeast of the mining town of Stewart, B.C.

IDM Mining Ltd. (IDMMF), closed Friday's trading session at $0.0428, even for the day, on 155,000 volume. The average volume for the last 3 months is 55,522 and the stock's 52-week low/high is $0.029/$0.076.

chart

Aerpio Pharmaceuticals, Inc. (ARPO)

Market Chameleon, Hot Stock Cafe, High Rising Stocks, Street Insider, Stocktwits, 4-Traders, Barchart, Zacks, Business Wire, OTC Markets, Morningstar, OTC Stock Picks, Insider Tracking, and MarketWatch reported beforehand on Aerpio Pharmaceuticals, Inc. (ARPO), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Aerpio Pharmaceuticals, Inc. focuses on first-in-class treatments for ocular diseases. The Company’s lead compound is AKB‐9778. This is a small molecule activator of the Tie2 pathway. It is in clinical development for the treatment of non-proliferative diabetic retinopathy. A biopharmaceutical Company, Aerpio Pharmaceuticals has its corporate office in Cincinnati, Ohio. The Company lists on the NasdaqCM.

Currently, AKB-9778 is in a Phase 2b study (TIME-2b) for the treatment of non-proliferative diabetic retinopathy (NPDR). Diabetic Retinopathy (DR) is a complication of diabetes caused by damage to blood vessels in the retina. AKB-9778 is undergoing development as a subcutaneous injection.

Aerpio Pharmaceuticals’ second program in development builds on its unique approach to targeting the Tie2 pathway. ARP-1536 is a humanized monoclonal antibody. It works by binding the extracellular domain of VE-PTP, inhibiting its ability to interact with the Tie2 receptor. This prevents the inactivation of Tie2. In addition, it promotes vascular stability.

ARP-1536 is in pre-clinical development. Aerpio’s plan is to develop ARP-1536 in combination with anti-VEGF therapy for the treatment of wet age-related macular degeneration (AMD) and diabetic macular edema (DME). Furthermore, AKB-4924 is in Phase 1 clinical development. The Company’s plan is to develop it as a once-daily, oral treatment for inflammatory bowel disease (IBD). AKB-4924 is an innovative small molecule inhibitor of prolyl-hydroxylase domain enzymes (PHDs).

In January, Aerpio Pharmaceuticals announced the completion of patient dosing in its TIME-2b study. This is the aforementioned Phase 2b clinical trial designed to assess the efficacy and safety of the Company’s lead candidate, AKB-9778, for patients with moderate to severe non-proliferative diabetic retinopathy (NPDR).

Stephen Hoffman, M.D., Ph.D., Chief Executive Officer of Aerpio Pharmaceuticals, said, "We are pleased to announce completion of patient dosing in our 48-week Phase 2b trial, TIME-2b. We now expect to announce top-line results in March 2019, earlier than our previous guidance of the second quarter of 2019.”

Last week, Aerpio Pharmaceuticals announced that its Q4 and full year 2018 financial results will be released before the market opens on Tuesday, March 5, 2019. Following the release, Aerpio will host a live conference call and webcast at 8:30 a.m. EST to discuss its financial results and provide a general business update.

Aerpio Pharmaceuticals, Inc. (ARPO), closed Friday's trading session at $2.97, down 0.67%, on 303,784 volume with 1,017 trades. The average volume for the last 3 months is 150,166 and the stock's 52-week low/high is $1.56/$5.19.

chart

AmeriCann, Inc. (ACAN)

NetworkNewsWire, SmallCapVoice, TheMicrocapNews, Dividend Investor, last10k, OTC Markets Group, Real Pennies, TopPennyStockMovers, Promotion Stock Secrets, and Cannabis Financial Network News reported earlier on AmeriCann, Inc. (ACAN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

AmeriCann, Inc. is developing sustainable, state-of-the-art, medical cannabis cultivation properties. The Company is a national leader of sustainable cultivation and processing infrastructure for the medical marijuana industry. OTCQB-listed, AmeriCann designs, builds, and owns efficient cultivation and processing facilities to produce medical cannabis. It is developing projects across the nation in regulated markets via the “Preferred Partner Program”. An Agricultural Technology Company, AmeriCann is based in Denver, Colorado.

AmeriCann identifies, acquires, and also develops real estate especially suited for cannabis operations. It finances real estate development. In addition, the Company provides necessary venture capital to developing cannabis businesses.

AmeriCann is developing a 53-acre property in Massachusetts as the Massachusetts Medical Cannabis Center (the MMCC). The MMCC has approval for close to 1 million square feet. The expectation is that it will be one of the most technologically advanced cultivation facilities in the nation. AmeriCann has agreements with Coastal Compassion, Inc. (CCI), its Preferred Partner in Massachusetts, to lease 100 percent of the initial phase of MMCC.

AmeriCann has its Preferred Partner in Massachusetts, Bask, Inc. (BASK of BASK Premium Cannabis). In 2016, AmeriCann formed an alliance with BASK as a Preferred Partner in Massachusetts. BASK is scheduled to be the first business to operate in AmeriCann's Massachusetts Medical Cannabis Center (MMCC). BASK is an established Massachusetts cannabis operator.

Recently, AmeriCann provided a construction update for its flagship Massachusetts Medical Cannabis Center (MMCC). Construction of the MMCC project is moving ahead quickly. Million of dollars have already been invested in site preparation, concrete, as well as steelwork. Over a dozen companies have been retained for construction of the facility that is being supervised by CBRE on behalf of AmeriCann.

The construction of Building 1, which is a 30,000 square foot cultivation and processing facility, is scheduled for completion this summer. The entire building will be 100 percent leased by an existing, vertically-integrated Massachusetts operator, Bask, Inc.

In February, AmeriCann announced that it executed a definitive agreement for the terms of a Joint Venture (JV) with Bask, Inc. at AmeriCann’s Massachusetts Medical Cannabis Center (MMCC). The MMCC is undergoing development on a 52-acre parcel in Southeastern Massachusetts. The MMCC project is permitted for 987,000 sq. ft. of cannabis cultivation and processing infrastructure that will be developed in phases and plans to support the existing medical cannabis and the newly emerging adult-use cannabis market. AmeriCann’s plan is to replicate the brands, technology and innovations developed at its MMCC project to new markets as a licensed multi-state operator (MSO).

AmeriCann, Inc. (ACAN), closed Friday's trading session at $1.87, down 1.58%, on 24,433 volume with 80 trades. The average volume for the last 3 months is 45,559 and the stock's 52-week low/high is $1.70/$4.69.

chart

Artelo Biosciences, Inc. (ARTL)

NetworkNewsWire, Stockwatch, MarketWatch, Simply Wall St, OTC Markets, Stockopedia, The Street, Dividend Investor, Digital Journal, Trading View, Biospace, GuruFocus, Stockhouse, Wallmine, Simply Wall St, Market Screener, Real Investment Advice, last10k, Market Exclusive, Venture Line, and InvestorsHub reported earlier on Artelo Biosciences, Inc. (ARTL), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company centered on the development of therapeutic treatments that modulate the endocannabinoid system. It is advancing a portfolio of widely applicable product candidates. The design of these is to address significant unmet needs in manifold diseases and conditions, including cancer, pain, and inflammation. Artelo Biosciences has its head office in La Jolla, California.

The endocannabinoid system (ECS) is a widespread neuromodulatory system. It plays a vital role in human central nervous system development, synaptic plasticity, and the response to endogenous and environmental insults.

Artelo Biosciences’ approach exploits numerous mechanisms to modulate the ECS. Candidate therapeutic compounds in its current portfolio are based on targeting cannabinoid receptors and endocannabinoid transport inhibition using synthetic cannabinoids and new chemical entity approaches.

Artelo’s emphasis is on providing patient access to new therapies and applying proven biopharma thoroughness to its development programs. Furthermore, it is driving innovative endocannabinoid system modulating therapeutics into new areas. The Company is also partnering with world-class experts.

Artelo Biosciences earlier entered into a global research and development (R&D) partnership with Syngene International Ltd., an India-based integrated discovery-development service provider, through its wholly-owned subsidiary, Trinity Research and Development Limited, and Aptus Clinical Ltd., a specialist UK-based Clinical Contract Research Organization (CRO) with specific expertise in oncology, rare diseases and advanced therapies. The partnership centers on supporting the drug discovery and clinical development of ART27.13, Artelo Biosciences’ Phase 2 ready, high-potency dual cannabinoid agonist, in oncology.

In October 2018, Artelo Biosciences announced positive preclinical results with its product candidate, ART27.13, a clinic-ready, potent, peripherally restricted CB1/CB2 synthetic agonist with a target indication in cancer-related anorexia and weight loss. Of note, ART27.13 demonstrated in-vitro anti-proliferative activity in cancer cell line cultures.

The results are alike to activity shown by other cannabinoid compounds. The Company says they are encouraging to the continued evaluation of ART27.13 as a potential anti-cancer agent, in addition to its expected role in treating anorexia. Artelo Biosciences is continuing clinical study-enabling activities for ART27.13 for a Phase 1b/2a study in cancer-related anorexia planned to begin this year.

Artelo Biosciences, Inc. (ARTL), closed Friday's trading session at $1.20, even for the day, on 10,300 volume with 10 trades. The average volume for the last 3 months is 509 and the stock's 52-week low/high is $0.27/$1.75.

chart

Gratitude Health, Inc. (GRTD)

Penny Stock Hub, Dividend Investor, Morningstar, Stockhouse, GuruFocus, Cannabis Daily, Zacks, Wallet Investor, Simply Wall St, MarketWatch, Investors Hangout, InvestorsHub, Trading View, The Street, Barchart, and 4-Traders reported previously on Gratitude Health, Inc. (GRTD), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Gratitude Health, Inc. manufactures, sells, and markets functional ready-to-drink (RTD) beverages under the Gratitude brand. The Company’s Founders, Mr. Roy Warren and Mr. Andy Schamisso, are beverage veterans with more than three decades of experience in the industry. Gratitude Health was formed to manufacture healthy, unique, and certified-organic beverages for a consumer market interested in healthy aging. Established in 2017, Gratitude Health is based in North Palm Beach, Florida and lists on the OTCQB.

Gratitude Health announced last year that it entered into a definitive exchange and spinoff agreement with Vapir Enterprises, Inc., previously traded under the symbol VAPI. The combination facilitated Gratitude Health, Inc. to become a publicly traded company. With the agreement, Vapir Management retains its operations, intellectual property (IP), assets, and liabilities. It will continue as a separate operating entity and will not be involved in the beverage business.  Vapir is a developer and manufacturer of vaporization devices.

Gratitude Health offers flavored and unsweetened RTD teas. The Company’s alternative food and beverage options are nutrient rich. They feature reduced or eliminated carbohydrate and sugar levels. Moreover, they are full of anti-oxidants and organic ingredients. Each bottle contains no more than 45 calories. Gratitude Health’s 16 oz proprietary bottles feature collectible debossed designs intended to be reused and repurposed.

The Company pan-roasts its tea by hand. Its tea flavors include Dragon Well Green Tea Peach; Dragon Well Green Tea Mint; Dragon Well Green Tea Wildberry; Dragon Well Green Tea Blood Orange; and Dragon Well Green Tea Original. Dragon Well tea (culturally known as "Longjing") comes from the pristine, certified-organic fields of Hangzhou China. Dragon Well tea has the distinction of being named "The Tea of Emperors". It is the most popular in The People’s Republic of China (PRC).

Gratitude Health’s next proprietary product line will further advance the Company mantra of providing healthy, functional drink offerings by specifically targeting what Gratitude call’s “nutrition for  aging.” The forthcoming line of innovative, nutrition-rich and balanced meal-replacement drinks will provide a scientifically proven weapon to battle this disease. Therefore, Gratitude Health has contracted with a world-class scientific advisory body to develop ketogenically balanced macro-nutrient delivery. The Company is nearing the end of this formulation and development process.

Recently, Gratitude Health announced its plans to launch KetoRefuel™. This is the world’s first Ready-to-Drink (RTD) line of ketogenic meal-replacement shakes. This product is targeted for launch in Q2 2019. The first drinks to launch in the KetoRefuel lineup will be Chocolate, Vanilla and Caffeinated Mocha Ketogenic Meal-Replacement Shakes in 16.9 oz, shelf-stable Tetra Pak® containers that are re-sealable and have been consumer-tested for user-friendliness.

Gratitude Health, Inc. (GRTD), closed Friday's trading session at $0.04328, up 1.84%, on 49,442 volume with 10 trades. The average volume for the last 3 months is 24,053 and the stock's 52-week low/high is $0.01/$0.15.

chart

Optex Systems Holdings, Inc. (OPXS)

Epic Stock Picks, Stock Beast, Penny Stock Newsletter, Stock Commander, MicroCapDaily, Damn Good Penny Picks, Penny Picks, Wolf of Penny Stocks, DSR News, DamnGoodPennyStock, William Velmer, PHUB News, OTCMagic, S.A. Advisory, PennyStockLocks, Prepump Stocks, and StockRockandRoll reported previously on Optex Systems Holdings, Inc. (OPXS), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Optex Systems Holdings, Inc. is a top manufacturer of optical sighting systems and assemblies, primarily for Department of Defense (DoD) applications. Additionally, the Company manufactures and delivers manifold periscope configurations, rifle and surveillance sights, and night vision optical assemblies. Optex Systems delivers its products directly to the military services and to prime contractors. OTCQB-listed, Optex Systems Holdings is based in Richardson, Texas.

Optex Systems, Inc. is a wholly-owned subsidiary of Optex Systems Holdings. Optex Systems’ products are installed on varied types of U.S. military land vehicles. These include the Abrams and Bradley fighting vehicles, Light Armored and Armored Security Vehicles. In addition, its products have been selected for installation on the Stryker family of vehicles.

Optex Systems manufactures the US Navy 20x 120mm Ship Binoculars. The Company also brings creative technology to vehicular mounted sighting systems. Its dismounted sighting systems work on weapon sights, night vision goggles, and any other sighting requirements outside of ships and land vehicles. Optex Systems can also meet commercial (non-military) requirements.

Recently, Optex Systems Holdings announced a $1.0 million order associated with its ongoing support of the M1 Abrams Tank Program. These products will be manufactured at the Applied Optics Center (AOC) Division of Optex Systems, Inc.

Mr. Bill Bates, GM of the AOC Division, said, “We are very proud of our continuing support to our domestic customer for these optical components and the fact that AOC is one of the few, if not the only, qualified supplier of these difficult to manufacture items. AOC employees understand the importance of reliable products when it comes to protecting our troops and their ability to complete their mission.”

In February, Optex Systems Holdings announced a $1.9 Million order from Defense Logistics Agency Troop Support, Philadelphia. These products will be manufactured at the Applied Optics Center (AOC) Division of Optex Systems, Inc. With this order, Optex Systems’ present backlog stands at greater than $28.2 million.

Optex Systems Holdings, Inc. (OPXS), closed Friday's trading session at $1.84, down 1.08%, on 16,800 volume with 15 trades. The average volume for the last 3 months is 24,055 and the stock's 52-week low/high is $0.961/$2.06.

chart

Terra Tech Corp. (TRTC)

Stock of the Week, Stockhouse, Epic Stock Picks, Street Register and Penny Stock Tweets reported on Terra Tech Corp. (TRTC), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Terra Tech Corp. is a vertically integrated cannabis-focused agriculture company. It operates through numerous subsidiary businesses. These include Blüm, IVXX Inc., Edible Garden, and MediFarm LLC. Terra Tech’s commitment is to cultivate and provide the highest quality medical cannabis and other agricultural products. Listed on the OTCQX, Terra Tech is based in Irvine, California.

Terra Tech is integrating the best of the natural world with technology to create sustainable solutions for medical cannabis production, extraction and distribution, plant science research and development, food production, and Closed Environment Agriculture (CEA).

IVXX, Inc. is a wholly-owned subsidiary of Terra Tech. IVXX produces cannabis-extracted products for regulated medical cannabis dispensaries throughout California and medical and adult-use dispensaries in the State of Nevada.

Terra Tech has its wholly-owned subsidiary Edible Garden. It cultivates a premier brand of local and sustainably grown hydroponic produce. It sells via major grocery stores. In New Jersey, construction is taking place for a major new pack house to distribute salads and leafy greens for Edible Garden.

Terra Tech's MediFarm LLC subsidiaries focus on medical and adult-use cannabis cultivation. Additionally, MediFarm subsidiaries focus on permitting businesses throughout Nevada.

Blüm offers a broad selection of cannabis products. These include flowers, concentrates, and edibles through its Oakland, California and many Nevada locations.

Terra Tech’s capital expenditures for this calendar year will be directed toward the build out of its cultivation, extraction, and retail infrastructure in California, Nevada and New Jersey. In Oakland, Terra Tech is building a 13,000-square-foot cultivation facility. This facility will have the capacity to produce up to one metric ton, or 2,000 pounds, of cannabis per year.

Terra Tech has completed construction in Nevada of a new 30,000 square foot cannabis cultivation facility in Sparks and a 15,000 square foot cannabis extraction facility in Reno through agreements with NuLeaf. The Company is awaiting final State approval to start IVXX production at the Reno facility.

In June, Terra Tech announced that it began cultivation at its new Sparks facility, following approval from the State of Nevada. The team has successfully started cultivation of its first cannabis crop, planting the first seeds in early June. The Company expects to distribute and sell cannabis grown at the Sparks facility from its first harvest throughout Nevada by Q4 2018.

Terra Tech Corp. (TRTC), closed Friday's trading session at $0.88, up 3.53%, on 3,574,127 volume with 1,989 trades. The average volume for the last 3 months is 1,272,669 and the stock's 52-week low/high is $0.461/$5.74.

chart

U.S. Stem Cell, Inc. (USRM)

InvestorsHub, MarketWatch, TradingView, and Money Morning reported on U.S. Stem Cell, Inc. (USRM), and today we report on the Company, here at the QualityStocks Daily Newsletter.

U.S. Stem Cell, Inc. is a developing business in the regenerative medicine/cellular therapy industry. The Company is a developer of novel autologous cell therapies, and a provider of physician-based stem cell therapies to human and animal patients. U.S. Stem Cell is based in Sunrise, Florida. The Company formerly went by the name Bioheart, Inc. It changed its name to U.S. Stem Cell, Inc. in October of 2015.

The Company has three operating divisions: US Stem Cell Training, Vetbiologics, and US Stem Cell Clinic. U.S. Stem Cell is a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions. Its concentration is on the discovery, development, and commercialization of cell-based therapeutics that prevent, treat, or cure disease through repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function.

U.S. Stem Cell’s business includes the development of proprietary cell therapy products and revenue generating physician and patient based regenerative medicine/cell therapy training services. In addition, the Company’s business includes cell collection and cell storage services, the sale of cell collection and treatment kits for humans and animals, and the operation of a cell therapy clinic.

U.S. Stem Cell’s lead product candidate is MyoCell®. This is a muscle stem cell therapy intended to improve cardiac function months or even years after a patient has suffered severe heart damage due to a heart attack.

MyoCell SDF-1 has received approval from the Food and Drug Administration (FDA) to commence human clinical trials. The intention of MyoCell SDF-1 is to be an improvement to MyoCell.

U.S. Stem Cell has developed a strategic alliance with Advanced Stem Cell Rx (ASC). This includes the development of autologous stem cell treatment centers across the United States. ASC is a U.S. based provider of regenerative medicine programs.

U.S. Stem Cell announced in January 2018 that it reached an important milestone of 10,000 kit sales of its proprietary Adipocell™ product. This is a direct result of its relationships with 287 clinics in the United States and 700-plus physicians worldwide offering the Company’s proprietary stem cell products and services.

Last month, U.S. Stem Cell announced Renewing Our Heroes - a charitable health initiative created to provide first responders and other civil service personnel with access to alternative medical care they would otherwise be unable to obtain - will now offer the Company’s stem cell procedures and protocols to its recipients following injuries and conditions that occur in the line of duty.

Mr. Mike Tomas, U.S. Stem Cell’s President and Chief Executive Officer, said, "Expansion of our stem cell protocol into the line of service for our first responders means we are starting to reach more and more Americans who otherwise would never have access to this incredible regenerative therapy. It is an honor for our organization to know the true heroes of our country can now have access to this standard of care."

U.S. Stem Cell, Inc. (USRM), closed Friday's trading session at $0.0298, up 5.67%, on 1,201,248 volume with 49 trades. The average volume for the last 3 months is 847,013 and the stock's 52-week low/high is $0.0106/$0.088.

chart

Cocrystal Pharma, Inc. (COCP)

Microcapmillionaires, Promotion Stock Secrets, Wall Street Resources, and PennyStocks Forever reported on Cocrystal Pharma, Inc. (COCP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cocrystal Pharma, Inc. develops novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. The Company employs innovative technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. The design of these technologies, including its nucleoside chemistry expertise and market-centered approach to drug discovery, are to efficiently deliver small molecule therapeutics that are safe, effective, and convenient to administer. Cocrystal Pharma has offices in Tucker, Georgia and Bothell, Washington.

A biotechnology enterprise, the Company’s proprietary technologies revolve around a structure-based drug discovery strategy teamed up with wide-ranging nucleoside experience. Using techniques called protein cocrystallization and X-ray crystallography, Cocrystal Pharma quickly identifies novel binding sites, identifies critical inhibitor-protein interactions, and optimizes the structure of the inhibitor in a highly rapid iterative fashion.

Cocrystal Pharma has identified promising, preclinical stage antiviral compounds for unmet medical needs. These include hepatitis, influenza, and norovirus infections.

The Company is developing a series of compounds that are potent non-nucleoside and nucleoside inhibitors of hepatitis C NS5B RNA dependent RNA polymerase, a replication enzyme crucial to viral replication and are highly conserved between all hepatitis C genotypes. As a result, inhibitors of this enzyme are likely to have multi- or pan-genotypic activity.

Cocrystal Pharma is also developing compounds that inhibit hepatitis C helicase and NS5A, two enzymes important for viral replication. The Company also has identified a picomolar inhibitor of NS5A; another important viral replication protein. Its compounds that target NS5B hepatitis C polymerase, NS5A, and NS3 helicase will undergo development as a combination treatment.

Recently, Cocrystal Pharma announced that its Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) is now open. Cocrystal Pharma is cleared to start its Phase 2a clinical study evaluating CC-31244 for the treatment of hepatitis C virus (HCV) infected individuals.

The Phase 2a study is an open-label study. The design of it is to evaluate the safety, tolerability and preliminary efficacy of CC-31244 with approved HCV drugs. Endpoints of the Phase 2a study include changes in HCV RNA viral load, adverse events and laboratory abnormalities.  The Company expects to begin its Phase 2a study of CC-31244 in Q2 of 2018 and announce data in Q4 of 2018.

For Q1 2018, Cocrystal Pharma reported a Net Loss of roughly $1,553,000 versus a Net Loss of roughly $2,548,000 for the same period in 2017. As of March 31, 2018, the Company had $1.2 million in cash and cash equivalents.

Cocrystal Pharma, Inc. (COCP), closed Friday's trading session at $2.90, up 0.69%, on 5,717 volume with 29 trades. The average volume for the last 3 months is 42,622 and the stock's 52-week low/high is $1.51/$6.45.

chart

Medovex Corporation (MDVX)

StockTwits reported on Medovex Corporation (MDVX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Medovex Corporation is the developer of the DenerveX® System. This is a new and novel device designed for enduring relief of Facet Joint Syndrome (FJS) related to chronic back pain, a non-addictive, non-opioid drug alternative capable of restoring a patient to a more normal and active lifestyle. The Company established to acquire and develop a diversified portfolio of potentially pioneering medical technology products. OTCQB-listed, Medovex is based in Atlanta, Georgia.

Facet Joint Syndrome (FJS) is also known as spinal osteoarthritis, spinal arthritis, or facet joint osteoarthritis. FJS is a significant health and economic problem in the U.S. and other countries in the EU and Rest of World affecting millions annually. Present treatment options are generally temporary. There is no proven long-lasting option for FJS.

The healthcare executives at Medovex have a proven record of accomplishment of building successful medical device and biotechnology companies. The Company’s DenerveX System is CE Marked in Europe. In addition, it is commercially available in Europe and certain other worldwide markets.

The DenerveX System is a highly differentiated technology. It denervates and removes capsular tissue from the Facet Joint in one single procedure. Treatment results from the combined effect of a deburring or polishing action and RF ablation treatment on the Facet Joint.

Employing this new technique, the slowly rotating burr removes the targeted facet joint synovial membrane and joint surface. This is while the heat ablation destroys tissue and denudes any residual nervous and synovial membrane overlying the joint, removing the end point sensory tissue of the joint.

In November, Medovex announced that it submitted an Investigational Device Exemption (IDE) with the U.S. Food and Drug Administration (FDA) for its DenerveX System targeting pain associated with the Facet Joint. The submission of the IDE marks a significant milestone for the Company.

This past September, Medovex announced that it launched its DenerveX System Device in Spain with leading distributor Prim SA. In October, Medovex announced that it launched its DenerveX System Device in Switzerland with distributor Spine Surgical. Switzerland is one of the most important locations for the worldwide medical technology industry.

Through combining first-class research facilities and highly-developed healthcare systems, Switzerland presents itself as a very attractive location for research, development and production for the medical technology sector.

The DenerveX System consists of the DenerveX Kit, which contains the DenerveX Device, a single use medical device and the DenerveX Pro-40 Power Generator. The DenerveX system is not yet FDA cleared.

Medovex Corporation (MDVX), closed Friday's trading session at $0.52, up 10.66%, on 165,918 volume with 25 trades. The average volume for the last 3 months is 44,400 and the stock's 52-week low/high is $0.2109/$0.65.

chart

Dais Analytic Corp. (DLYT)

HotOTC, SmallCapVoice, CoolPennyStocks, MadPennyStocks, StockEgg, StockRich, Stockpalooza, Money Morning, Penny Stock Rumble, FeedBlitz, M2 Communications, SmallCap Pulse, BullRally, PennyInvest, PennyStockVille, and Greenbackers reported earlier on Dais Analytic Corp. (DLYT), and today we are highlighting the Company , here at the QualityStocks Daily Newsletter.

Dais Analytic Corp sells its industry-changing nanomaterial technology into the global water, air, and energy markets. A commercial nanotechnology materials enterprise, the Company provides nanotechnology-based applications for heating & cooling, water treatment, and energy storage. It is commercializing its unique Aqualyte™ family of nano-structured materials and processes centering on disruptive air, energy, and water applications. Dais Analytic is headquartered in Odessa, Florida.

The uses of the Aqualyte™ family of nano-structured materials and processes include ConsERV™. This is a commercially available engineered energy recovery ventilator (a heating, ventilation, and air conditioning (HVAC) product).

In addition, the uses include NanoAir™. This is an early beta-stage water-based, no fluorocarbon producing refrigerant cooling cycle. Uses also include NanoClear™. This is an early beta-stage method for treating contaminated water to provide 1,000 times cleaner potable water.

The NanoClear™ process has consistently shown that Dais Analytic’s novel Aqualyte® material can separate most contaminants from water, realizing almost 'parts per billion' clean product water with little or no fouling of the vital membrane component.

NanoClear™ is a leading-edege water cleaning architecture enabled by the features in the Company’s nanomaterial - Aqualyte™. The NanoClear™ product line is a critical application in purifying contaminated water having high salt content, low pH, or where the requirement for Total Dissolved Solid (TDS) in the product water is 10 or less.

Furthermore uses include NanoCAP™. Dais indicates that NanoCAP™ holds promise to use the Aqualyte™ family to form a disruptive, non-chemical, energy-storage device (an ultra-capacitor) when completed for use in transportation, renewable energy, and also 'smart grid' configurations.

This past summer, Dais Analytic announced it signed a 7 year, non-exclusive agreement with the Menred Group, Zhejiang province, China, to provide its Aqualyte moisture transfer nanomaterial for use in a newer line of Menred energy recovery ventilators (ERV) to sell into the increasing Chinese heating, ventilation and air conditioning (HVAC) market.

Energy Recovery Ventilators are used in association with HVAC equipment to save capital and operating costs. This is while improving the quality of life for the building's occupants.

High effectiveness ERVs, such as ConsERV™ or Menred Group's new line of ERVs to be built utilizing Dais Analytic's Aqualyte nanomaterial, enable architects and engineers to design buildings with considerable volumes of filtered, preconditioned supply air.

Mr. Brian Johnson Dais Analytic’s Chief Technology Officer, said in July 2017, "Dais' ConsERV™ has long been a leader in this field as established by our Air-Conditioning, Heating and Refrigeration Institute (AHRI) certified performance -- along with other similar ratings from 3rd party rating company's worldwide. Our Aqualyte™ nanomaterial, now in its 4th generation, drives this performance and we are excited about working with Menred to bring a new series of ERVs with Aqualyte to the growing Chinese ERV market."

Dais Analytic Corp. (DLYT), closed Friday's trading session at $0.0085, up 11.84%, on 112,000 volume with 4 trades. The average volume for the last 3 months is 113,713 and the stock's 52-week low/high is $0.007/$0.0875.

chart

Oculus VisionTech, Inc. (OVTZ)

UltimatePennyStock and Profit Status reported earlier on Oculus VisionTech, Inc. (OVTZ), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Oculus VisionTech, Inc. creates systems for document and multimedia protection to fight tampering and digital piracy. The Company designs and markets, to business customers, streaming video content distribution, and Internet Cloud-based digital document protection, based on embedded digital watermarking, and Video-on Demand (VOD) systems, services, and source-to-destination digital media delivery solutions that permit live or recorded digitized and compressed video to be transmitted via the Internet, intranet, satellite, or wireless connectivity.

Oculus VisionTech is based in Vancouver, British Columbia and the Company lists on the OTCQB. The Company previously went by the name USA Video Interactive Corp. It changed its name to Oculus VisionTech, Inc. in January of 2012.

Oculus VisionTech’s Document Watermarking Protection technology will be provided as a Cloud service – Cloud DPS. Cloud DPS provides three document services from the Cloud. One is Protection - accept any incoming document, watermark and return the watermarked document as an encrypted image-based PDF document. The second is Authenticate - validate the authenticity of the protected documents. The third is Storage - storage of the master protected document in digital.

The Company’s systems, services, and delivery solutions include document, still image and motion video digital watermark solutions and documents, photographs (still image) and video content protection. Oculus' technology includes Cloud-DPS. At present, it is promoting the imaged-based Document Protection System (DPS) and developing manifold other products. Before the DPS, Oculus created proprietary technology called Smart Marks, which created imperceptible watermarks for videos.

The Company has developed its first proprietary document viewer application (the Document Viewer) for its DPS technology. This is an important addition to the online digital document protection set it has been developing.

The present version of the Document Viewer is for the Windows operating system. Additionally, Oculus is continuing to develop applications for Mac, iOS, and Android operating systems.

Fundamentally, the Cloud DPS is a system made to protect and authenticate digital documents from tampering. Cloud DPS is meant for documents at the end of the editing cycle.

Furthermore, Cloud DPS creates Visible Watermarks (QR Codes). The core technology in the DPS is the Anti-Tampering Technology.

The construction of the Cloud DPS system is on two chief processes, protection and authentication. Protection changes documents into image based files, which include multiple levels of security. This includes encryption, edit-locking, watermarking, and a state-of-the-art onboard master copy system. Authentication is the process of checking the in document master copy to determine the authenticity of a document.

Oculus VisionTech, Inc. (OVTZ), closed Friday's trading session at $0.08, up 3.16%, on 17,982 volume with 37 trades. The average volume for the last 3 months is 69,181 and the stock's 52-week low/high is $0.054/$0.1765.

chart

Uniroyal Global Engineered Products, Inc. (UNIR)

Zacks, MarketWatch, and Marketbeat.com reported on Uniroyal Global Engineered Products, Inc. (UNIR), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Uniroyal Global Engineered Products, Inc., by way of its subsidiaries, is a foremost manufacturer of vinyl coated fabrics. These fabrics are durable, stain resistant, cost-effective alternatives to leather, cloth, and other synthetic fabric coverings. Formed in 1992, Uniroyal Global Engineered Products (UNIR) is based in Sarasota, Florida. The Company’s shares trade on the OTCQB.

UNIR is a top supplier of vinyl coated fabric materials for the automotive and commercial industries. The Company’s products in the automotive industry are used largely in seating, door panels, head and arm rests, security shades, and trim components.

UNIR’s non-automotive applications include outdoor seating for utility and sports vehicles, and sheeting used in medical, nuclear protection, personal protection, moisture barriers, pool liners, pram and nursery, movie screen, and decorative surface applications.   

The Company’s chief brand names include Naugahyde®, BeautyGard®, Flameblocker™, and Spirit Millennium®. In addition, they include Ambla®, Amblon®, Velbex®, Cirroflex®, Plastolene® and Vynide®.

The Company’s 2016 revenue was derived 65 percent from the automotive industry and about 35 percent from the recreational, industrial, indoor and outdoor furnishings, hospitality, and health care markets.

In 2016, UNIR’s Naugahyde brand introduced Casablanca. This is a linen-textured vinyl-coated fabric. Casablanca combines the look and feel of linen with the performance of Naugahyde®.

All of Casablanca’s patterns are flame retardant, stain resistant, as well as anti-microbial. Casablanca features Naugahyde’s exclusive Advanced BeautyGard® top coat finish. This collection was developed with hospitality, contract, marine, and healthcare markets in mind.

In November, Uniroyal Global Engineered Products reported its financial results for Q3 ended October 1, 2017.

Mr. Howard R. Curd, Chairman and Chief Executive Officer of UNIR, said, “Overall, this was a very tough quarter from a sales perspective. The reported decline in Net Sales is isolated to our North American operations as we continue to see gains in our European operations.  The North American operations struggled with sharply lower volume, particularly in the automotive sector as volume expectations from certain platforms were not achieved. US consumer preferences are switching to light trucks, SUVs and crossovers which are not significant drivers of our revenue. As a result, many of the US automotive manufacturers idled production lines or entire assembly plants for multiple weeks to reduce inventories. We have taken corrective action to “right size” the costs associated with the lower volumes as well as eliminate certain administrative expenses.”

The Company reported net sales of $22,498,456 and a net loss available to common shareholders of $477,553 or a loss of $0.03 per diluted share for Q3.

Uniroyal Global Engineered Products, Inc. (UNIR), closed Friday's trading session at $1.50, up 3.45%, on 10,536 volume with 16 trades. The average volume for the last 3 months is 1,647 and the stock's 52-week low/high is $1.00/$2.04.

chart

The QualityStocks Company Corner

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Innovative biotechnology company Earth Science Tech (OTCQB: ETST), in an effort to further expand and gain loyalty within the cannabis market, is collaborating with its marketing partner to launch a strategic white-labeling program. To view the full press release, visit: http://nnw.fm/OHQf5.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.70, up 2.94%, on 8,422 volume with 14 trades. The average volume for the last 3 months is 34,538 and the stock's 52-week low/high is $0.421/$2.45.

Recent News

chart

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF)

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation (FLWR).

The Flowr Corporation (TSXV: FLWR) (OTC: FLWPF) ("Flowr" or the "Company"), a Canadian Licensed Producer of premium cannabis products, today announced the hiring of celebrated Canadian Chef Ryan Reed to develop signature edible cannabis products for the Flowr brand. Chef Reed, a past winner of Iron Chef and Chopped and Victoria's 2011 Chef of the Year, will collaborate closely with Flowr's R&D Team to research and develop high-quality edibles. Also today, NetworkNewsWire released a report on the company detailing how FLWR expects its ability to produce clean cannabis at consistently high quality to be a crucial differentiating factor as the medical and recreational markets in Canada develop.

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $5.55, up 3.74%, on 435,429 volume with 860 trades. The average volume for the last 3 months is 115,400 and the stock's 52-week low/high is $2.74/$8.00.

Recent News

chart

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings (OTCQB: GRYN), a full-scope, premium cannabis company, is advancing science-driven cannabis cultivation systems and fostering greater growing efficiency via the use of an enhanced hybrid aeroponic method. To view the full article, visit: http://nnw.fm/gI67A.

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $0.54, up 6.30%, on 14,850 volume with 15 trades. The average volume for the last 3 months is 23,767 and the stock's 52-week low/high is $0.051/$0.579.

Recent News

chart

Pacific Software, Inc. (PFSF)

The QualityStocks Daily Newsletter would like to spotlight Pacific Software, Inc. (PFSF).

Emerging business development technology innovator Pacific Software (OTC: PFSF) is leveraging its proprietary BOAPIN cross-border blockchain trading platform as the centerpiece of a new partnership with China and FIERO, a leading Brazilian trade association focused on developing and promoting the economy of Rondônia. To view the full article, visit: http://nnw.fm/hyH5K.

Pacific Software, Inc. (PFSF) is an emerging technology corporation positioned for investments, mergers and acquisitions of software technologies and platforms. The company is building “BoaPin,” a subscription-based e-commerce trading platform focused on cross border trade expansion with an international emphasis. The multi-faceted e-commerce platform is scheduled for launch in Q1 of 2019.

The Company is uniquely positioned to deliver a B2B and B2C intelligent e-commerce trade platform which will provide various solutions, data, applications and tools for subscribers, including IBM’s Hyperledger Blockchain “Backend as a Service” (BaaS) Infrastructure, multi-lingual communication, fintech, digital marketing, smart contracts, commodities search/match applications, customs clearance, taxation data, product advertising and logistics solutions.

Through smart contract technology for global supply chain management, BoaPin is designed to improve product traceability and deliver solutions to its subscribers for product certification, marketing, logistics, commodities search/match interface, trade finance, cross border payment solutions and customs clearance. Some of the tools available to execute these capabilities include cross border payments, blockchain solutions, smart contracts and multilingual access.

With these features at hand, the company is targeting several key industries where its online applications and solutions could have significant corporate impact in various forms, including: agriculture, fertilizers, chemicals, cosmetics, electronics, equipment, apparel and controlled substance management.

Business Model

Pacific Software initially will focus on Brazil and China for BoaPin. After paying a registration fee to utilize the online trade portal, subscribers to the platform will have access to a variety of tools and features that may enhance and increase revenue initiatives by showcasing their commodities and products for sale or trade.

Buyers of the commodities, products or services will pay a transaction fee only to the company which could materialize in the form of cash, cash equivalents, royalties or in-kind fees.

As the company executes its strategy, the online trade business is anticipated to generate significant revenue from subscribers obtained from regionally and federally organized Brazilian Trade Associations. The members wish to market their commodities or products, and the portal users or buyers materialize from China, Hong Kong and surrounding countries. As a result, this business model may be organized separately in the company’s wholly owned subsidiary, incorporated as HyperSoft Ventures, which could generate appreciable value for investors and shareholders.

Pacific Software, Inc. (PFSF), closed the day's trading session at $5.50, even for the day. The stock's 52-week low/high is $3.50/$5.50.

Recent News

chart

Icon Exploration Inc. (TSX.V: IEX.H)

The QualityStocks Daily Newsletter would like to spotlight Icon Exploration Inc. (IEX.H).

Icon Exploration Inc. (TSX.V: IEX.H) is looking ahead toward challenges within the Canadian cannabis industry and strategically preparing for the long game. Icon sees potential beyond crop yield, a major focus of other companies, and is focusing on lowering production costs while creating and refining efficient extraction and processing methodologies. City View Green Holdings Inc. (formerly Icon Exploration Inc.) (the "Company") is pleased to announce that on the opening of the market on March 5, 2019, the Company's common shares will commence trading through the facilities of the Canadian Securities Exchange ("CSE"). The common shares will trade under the symbol "CVGR".

Icon Exploration Inc.'s (TSX.V: IEX.H) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.

CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.

Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.

Management

Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.

Market Opportunity

The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.

Icon Exploration Inc. (TSX.V: IEX.H), closed the day's trading session at $0.41, even for the day.

Recent News

chart

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN)

The QualityStocks Daily Newsletter would like to spotlight Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN).

A partnership between Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) and a subsidiary of Glencore plc (OTC: GLCNF) (OTC: GLNCY) is anticipated to provide a material amount of the funding needed for the construction of Black Iron’s Shymanivske Iron Ore Project.

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) is a Canadian iron ore exploration and development company advancing to production its wholly owned Shymanivske Iron Ore Project, located in Krivyi Rih, Ukraine. Black Iron’s Shymanivske project is situated in the southern part of the historic KrivBass iron ore mining district, a highly developed iron ore mining region with well-established infrastructure and nearby skilled labor forces. Surrounded by seven producing iron ore mines, the Shymanivske project will produce an ultra-high-grade, 68-percent iron ore concentrate with few impurities at very low cost.

The Market

Iron ore concentrates are one of the essential raw materials used by the steel industry to either make sinter or highly valued pellets. Black Iron’s concentrate can be used in either application and is an ideal source to make pellets since it does not need to be ground finer and contains very few impurities. According to the CRU Group, an internationally recognized top global business intelligence provider and consultancy specializing in commodities, there is a growing global shortage of pellet feed resulting in a supply/demand gap of 133Mt against the current base of approximately 400Mt consumed by 2035. According to a recent report issued by Zion Market Research, the global iron ore pellets market was valued at around US$25.22 billion in 2017 and is expected to reach US$50.12 billion by 2024, growing at a compound annual growth rate (CAGR) of 8.1 percent between 2018 and 2024 (http://nnw.fm/2vaDR).

Countries around the world, most notably China (http://nnw.fm/Je8gs), have instituted regulatory changes to curb polluting emissions from steel mills through numerous methods, including encouraging a shift to higher grade iron feed products such as pellets as less coal needs to be burnt per ton of steel produced.

Shymanivske Project

Black Iron’s Shymanivske’s project, which is expected to produce ultra-high-grade 68 percent iron content pellet feed iron concentrate, is generating significant interest from steel mills and global commodity trading houses. Use of ultra-high-grade 68-percent iron content product in the production of steel is a value-added product to customers since it increases blast furnace productivity and reduces greenhouse gas emissions generated per ton of steel produced.

The project’s proximity to rail lines (1 mile), electrical power (20 miles), sea ports (140 to 260 miles) and a skilled workforce (6 miles) significantly reduces the up-front construction costs and allows for the mine to be built in a phased approach. The Shymanivske project has been ranked by the CRU Group in the lowest position of the business cost curve for pellet feed projects currently under development and as the second lowest in capital intensity (construction capital divided by annual production) within CRU Group’s extensive database (http://nnw.fm/3MXsT). This low-cost position makes the project economics very robust to any shocks in iron ore price while providing a very high return at current and forecast prices.

Black Iron continues to advance its project on several fronts including construction funding and off-take agreements (http://nnw.fm/tQ4g2). Discussions with Ukraine’s Ministry of Defense to transfer a parcel of land required by the company for location of its processing plant, waste rock and tailings are nearing finalization, as are discussions with the Kryviy Rih City Council to lease a portion of the surface rights currently under that body’s control. The recent engagement of Ivan Markovich as Black Iron’s Vice President of Government and Community Relations will assist the company in these endeavors given his extensive network of relationships with senior Ukraine government officials.

The Shymanivske project holds a mining allotment permit for a large iron ore deposit with a NI 43-101 compliant resource estimated to contain 646 Mt (million tons) Measured and Indicated mineral resources, consisting of 355 Mt Measured mineral resources grading 31.6% total iron and 18.8% magnetic iron, and Indicated mineral resources of 290 Mt grading 31.1% total iron and 17.9% magnetic iron, using a cut-off grade of 10% magnetic iron. Additionally, there are 188 Mt of Inferred mineral resources grading 30.1% total iron and 18.4% magnetic iron.

Full mineral resource details and project economics can be found in the NI 43-101 compliant technical report entitled “Preliminary Economic Assessment of the Re-scoped Shymanivske Iron Ore Deposit” effective November 21, 2017, under the Company’s profile on SEDAR at?www.sedar.com.

Management

Black Iron’s management and board of directors is stacked with experts well-versed in successfully building and operating iron ore projects. CEO Matt Simpson, P.Eng. is the former general manager of Mining for Rio Tinto’s Iron Core Company of Canada and worked for Hatch designing global metallurgical refineries. He is also a Qualified Person as defined by NI 43-101. Chairman Bruce Humphrey is the former COO of GoldCorp and former chairman of Consolidated Thompson Iron Ore mines which was sold to Cliff’s resources for US$4.9 billion.

Les Kwasik, COO, has over 40 years of hands-on experience building and operating mines globally with companies such as INCO (VALE) and Xstrata (Glencore). Paul Bozoki, CFO, is the former CFO of CD Capital Partners, operating in the Ukraine. Bill Hart, senior vice president of corporate development, has over 30 years of experience selling iron ore while working for Rio Tinto, Cliffs Natural Resources and most recently Roy Hill Holdings Ltd. Ivan Markovich was recently engaged in the capacity of Black Iron’s vice president of Government and Community Relations to leverage his extensive network of relationships with senior Ukraine government officials.

Black Iron Inc. (BKIRF), closed the day's trading session at $0.054, even for the day, on 123,500 volume with 7 trades. The average volume for the last 3 months is 34,070 and the stock's 52-week low/high is $0.0285/$0.0939.

Recent News

chart

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

Leading omni-direct lifestyle company Youngevity International (NASDAQ: YGYI) announced on Thursday that its wholly-owned subsidiary, Khrysos Industries, has closed on a 45-acre area of land in Central Florida. The multi-purpose site will hold a 5-acre greenhouse, a research and development (“R&D”) facility committed to hemp plant genetic research, a post processing tolling facility, and 20 acres of farmable land for future use. To view the full press release, visit: http://nnw.fm/0waTj.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $6.99, off by 1.69%, on 106,251 volume with 561 trades. The average volume for the last 3 months is 208,950 and the stock's 52-week low/high is $3.167/$16.25.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) was featured today in the 420 with CNW by CannabisNewsWire.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $4.48, off by 3.24%, on 801,161 volume with 1,838 trades. The average volume for the last 3 months is 579,165 and the stock's 52-week low/high is $2.40/$11.82.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was highlighted today in a report examining the growing acceptance of cannabidiol (CBD) is resulting in heightened visibility, as CBD-infused products are now hitting malls across the USA.  

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $3.65, off by 1.74%, on 233,906 volume with 462 trades. The average volume for the last 3 months is 207,965 and the stock's 52-week low/high is $1.8068/$5.205.

Recent News

chart

TransCanna Holdings Inc. (CSE: TCAN)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

Emerging cannabis branding, transportation and distribution company TransCanna Holdings (CSE: TCAN) (FSE: TH8) recently accepted a Northern California real-estate option agreement with what looks to be significant potential. To view the full article, visit: http://nnw.fm/3mHnv.

TransCanna Holdings Inc. (CSE: TCAN) through its subsidiaries specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. TransCanna offers or will be offering services to support almost every aspect of the cannabis-related eco-system; from branding and design, to transportation and distribution, to marketing and sales.

California’s legalized adult-use recreational marijuana market opened for business January 1, 2018. The state’s Bureau of Cannabis Control is responsible for regulating all commercial activities in the state including cultivation, distribution and transportation. Moving cannabis products in the California marketplace is extremely challenging due to municipal and state laws and regulations, which can differ among cities and counties. Since cannabis remains illegal under federal law, Department of Transportation regulated companies are barred from participating in the market, which means companies looking to excel in the sector must hold a state-issued distributor license from the Bureau of Cannabis Control.

TransCanna has already entered into an Intellectual Property Rights and Royalty Agreement for the Track & Trace software platform required by the state of California. TCM Distribution, the operating company managed by TransCanna, has received a transportation and distribution permit from the city of Adelanto and a temporary transportation and distribution permit from the state of California. TransCanna has also executed a land lease to build a 10,000-square-foot transportation and distribution facility in Adelanto.

TransCanna is strategically creating a distribution network throughout California that places its facilities no further than a three-hour drive from most any client. The company is in the process of leasing or purchasing properly licensed and permitted warehouses strategically located throughout California along with new secure trucks, sprinter vans and/or armored vehicles.

TransCanna plans to create its own portfolio of branded products for the cannabis and hemp sectors. The company’s management team intends to translate the skills, knowledge and experience gained from a combined 60 years of branding and marketing experience in the music, professional sports and alcohol industries into TransCanna and the cannabis industry.

As part of the “TransCanna Way,” the company intends to manage most aspects of the supply chain from upper end procurement, branding, transportation and distribution, to marketing and sales.

Leading TransCanna as its CEO and chairman is James Pakulis, who has three decades of experience working with public and private entrepreneurial companies in a variety of emerging and high-growth sectors. He is formerly the president and a director of Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF), a vertically integrated cannabis-related entity operating in California. Pakulis was chairman and CEO of General Cannabis Inc. which from 2010 to 2012 owned WeedMaps. Pakulis oversaw the company’s growth from zero to over $16 million in annual revenue in less than 24 months.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

For additional information, call: (604) 609-6199

TransCanna Holdings Inc. (CSE: TCAN), closed the day's trading session at $2.65, off by 4.68%, on 65,580 volume with 68 trades. The stock's 52-week low/high is $0.769/$2.90.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com (OTCQB: CIIX), initially facing troubling times after its founding in 1999, is now a successful publicly traded company in the process of a potential uplisting to the Nasdaq. To view the full article, visit: http://nnw.fm/mU9Ub. Also today, the company was featured today in the 420 with CNW by CannabisNewsWire.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed the day's trading session at $0.475, off by 4.04%, on 43,032 volume with 24 trades. The average volume for the last 3 months is 95,033 and the stock's 52-week low/high is $0.365/$1.25.

Recent News

chart

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G), through its recent acquisition of Infusion Biosciences, owns revolutionary technology that its CEO Keith Dolo describes as “the world’s first and only truly water-soluble cannabis solution and bio-natural oils.” To view the full article, visit: http://nnw.fm/8yVJ7.

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.

Management

Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed the day's trading session at $0.30874, off by 1.74%, on 234,685 volume with 112 trades. The average volume for the last 3 months is 282,275 and the stock's 52-week low/high is $0.189/$1.875.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring SinglePoint Inc. (OTCQB: SING), a client of NNW focused on acquiring companies that will benefit from the injection of growth capital and technology integration. To view the full publication, titled “Companies Exploring Solar Energy, Establishing Foothold in Hot Industry,” visit: http://nnw.fm/RbZC4.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0193, off by 1.78%, on 1,928,748 volume with 115 trades. The average volume for the last 3 months is 6,395,874 and the stock's 52-week low/high is $0.0106/$0.0709.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Market opportunities for the hemp-based cannabidiol (“CBD”) product industry in the U.S. are many and growing now that hemp is legally protected following passage of the 2018 Farm Bill in December. Innovative hemp and cannabis corporation Marijuana Company of America Inc. (OTCQB: MCOA) is well positioned to take advantage of this shift in the legal landscape, with a variety of portfolio companies operating within the cannabis and hemp industries (http://nnw.fm/M6z4J).

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0132, off by 1.12%, on 6,517,609 volume with 276 trades. The average volume for the last 3 months is 14,202,115 and the stock's 52-week low/high is $0.0115/$0.0498.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.